February 26, 2015 11:29 PM ET

Biotechnology

Company Overview of OPKO Biologics

Key Executives for OPKO Biologics

NameBoard RelationshipsTitleAge
Abraham Havron Ph.D.59 RelationshipsChief Executive Officer and Director66
Shai Novik M.B.A.15 RelationshipsPresident, Director and Member of Governance Committee48
Steven Schaeffer CPANo RelationshipsChief Financial Officer and Principal Accounting Officer64
Fuad Fares D.Sc. 28 RelationshipsDirector and Chief Scientific Officer of Prolor Biotech Ltd59
Eyal Fima M.B.A., Ph.D.No RelationshipsChief Operating Officer of Prolor Biotech Ltd49

OPKO Biologics Board Members*

NameBoard RelationshipsPrimary CompanyAge
Phillip Frost M.D., Ph.D. 159 RelationshipsOpko Health, Inc.77
Abraham Havron Ph.D. 59 RelationshipsOPKO Biologics66
Shai Novik M.B.A. 15 RelationshipsOPKO Biologics48
Fuad Fares D.Sc. 28 RelationshipsOPKO Biologics59
Steven D. Rubin J.D. 99 RelationshipsOpko Health, Inc.54
View All Board Members

OPKO Biologics Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Corporate Governance Committee M.D., Ph.D.Phillip Frost159 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$270.0K
270.0K
334.7K
Bonus$60.0K
60.0K
188.7K
Total Short Term Compensation
Not meaningful
Total Value of Options$330.0K
330.0K
9.4M
Compensation as of Fiscal Year 2012
OPKO Biologics CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Hipolin Limited Announces Management Appointments
February 23, 2015 10:19 AM ET
Harbinger Group Inc. Appoints Curtis Glovier as Class II Director
February 20, 2015 10:05 PM ET
Spectrum Brands Holdings, Inc. Elects Joseph S. Steinberg as Director
February 20, 2015 9:11 PM ET
John R. Alm Announces Not to Stand for Re-Election as a Director of Kimberly-Clark Corporation
February 20, 2015 2:59 PM ET
Kimberly-Clark Corporation Announces Management Changes
February 18, 2015 9:20 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OPKO Biologics, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.